Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Hepatocellular Carcinoma (HCC)

  • Chapter
Percutaneous Tumor Ablation in Medical Radiology

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

  • 1138 Accesses

Abstract

Hepatocellular carcinoma (HCC) is considered to be one of the most common malignancies worldwide, and the most common one in Africa and Asia. Over the last decade, a rising incidence of up to 10–15/100,000 per population has been seen in the Western world, with an estimate of 250,000 deaths and more than a million worldwide per year. By the year 2010, the World Health Organization expects that HCC will be the leading cause of cancer mortality surpassing lung cancer. This increasing incidence is most likely related to an increasing prevalence of chronic hepatitis C (HC) and B (HB) virus infections and other diseases inducing chronic inflammation (Befeler and Di Bisceglie 2002; Llovet et al. 2003).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aguayo A, Patt YZ (2001) Nonsurgical treatment of hepatocellular carcinoma. Semin Oncol 28:503–513

    Article  PubMed  CAS  Google Scholar 

  • Akashi Y, Koreeda C, Enomoto S et al (1991) Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases. Hepatology 14:262–268

    PubMed  CAS  Google Scholar 

  • Alvarez R, Banares R, Echenagusia A et al (2000) [Prognostic factors for survival following transarterial chemoembolization in advanced hepatocellular carcinoma.] Gastroenterol Hepatol 23:153–158

    PubMed  CAS  Google Scholar 

  • Ariel I (1965) Treatment of inoperable primary pancreatic and liver cancer by the intra-arterial administration of radioactive isotopes (Y90 radiating microspheres). Ann Surg 162:267–278

    Article  PubMed  CAS  Google Scholar 

  • Befeler AS, Di Bisceglie AM (2002) Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 122:1609–1619

    Article  PubMed  Google Scholar 

  • Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430

    Article  PubMed  CAS  Google Scholar 

  • Burrel M, Llovet JM, Ayuso C et al (2003) MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 38:1034–1042

    PubMed  Google Scholar 

  • Camma C, Schepis F, Orlando A et al (2002) Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224:47–54

    Article  PubMed  Google Scholar 

  • Carr B (2004) Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 10(2) [Suppl. 1]:107–110

    Article  Google Scholar 

  • Chen MH, Yang W, Yan K et al (2005) Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications. World J Gastroenterol 11:6395–6401

    PubMed  Google Scholar 

  • Choi D, Lim HK, Kim MJ et al (2004) Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 230:135–141

    Article  PubMed  Google Scholar 

  • Chui AK, Rao AR, Island ER et al (2004) Multimodality tumor control and living donor transplantation for unresectable hepatocellular carcinoma. Transplant Proc 36:2287–2288

    Article  PubMed  CAS  Google Scholar 

  • Dancey JE, Shepherd FA, Paul K et al (2000) Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres [In Process Citation]. J Nucl Med 41:1673–1681

    PubMed  CAS  Google Scholar 

  • El-Serag HB, Mason AC (2000) Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 160:3227–3230

    Article  PubMed  CAS  Google Scholar 

  • Fuster J, Charco R, Llovet JM et al (2005) Liver transplantation in hepatocellular carcinoma. Transpl Int 18:278–282

    Article  PubMed  Google Scholar 

  • Geschwind JF, Salem R, Carr BI et al (2004) Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 127:S194–S205

    Article  PubMed  CAS  Google Scholar 

  • Goin JE, Salem R, Carr BI et al (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. J Vasc Interv Radiol 16:195–203

    PubMed  Google Scholar 

  • Hatanaka Y, Yamashita Y, Takahashi M et al (1995) Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management. Radiology 195:747–752

    PubMed  CAS  Google Scholar 

  • Hsieh MY, Chang WY, Wang LY et al (1992) Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors. Cancer Chemother Pharmacol Suppl 31:S82–S85

    Article  Google Scholar 

  • Huppert PE, Lauchart W, Duda SH et al (2004) Chemoembolization of hepatocellular carcinomas: which factors determine therapeutic response and survival? Rofo 176:375–385

    PubMed  CAS  Google Scholar 

  • Ikeda K, Kumada H, Saitoh S et al (1991) Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model. Cancer 68:2150–2154

    Article  PubMed  CAS  Google Scholar 

  • Johnson EW, Holck PS, Levy AE et al (2004) The role of tumor ablation in bridging patients to liver transplantation. Arch Surg 139:825–829; discussion 829–830

    Article  PubMed  Google Scholar 

  • Jungst C, Cheng B, Gehrke R et al (2004) Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma. Hepatology 39:1663–1672

    Article  PubMed  CAS  Google Scholar 

  • Lau WY, Ho S, Leung TW et al (1998) Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys 40:583–592

    Article  PubMed  CAS  Google Scholar 

  • Lencioni R, Paolicchi A, Moretti M et al (1998) Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and longterm survival rate. Eur Radiol 8:439–444

    Article  PubMed  CAS  Google Scholar 

  • Lencioni RA, Allgaier HP, Cioni D et al (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228:235–240

    Article  PubMed  Google Scholar 

  • Lencioni R, Crocetti L, Cioni D et al (2004) Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol 39:689–697

    Article  PubMed  Google Scholar 

  • Lencioni R, Cioni D, Crocetti L et al (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–967

    Article  PubMed  Google Scholar 

  • Lin SM, Lin CJ, Lin CC et al (2004) Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ? 4 cm. Gastroenterology 127:1714–1723

    Article  PubMed  Google Scholar 

  • Liu MD, Uaje MB, Al-Ghazi MS et al (2004) Use of Yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma. Am Surg 70:947–953

    PubMed  Google Scholar 

  • Livraghi T (2001) Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Hepatogastroenterology 48:20–24

    PubMed  CAS  Google Scholar 

  • Livraghi T, Meloni F, Morabito A et al (2004) Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center. Liver Transpl 10:S98–S106

    Article  PubMed  Google Scholar 

  • Llovet JM, Bru C, Bruix J (1999a) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329–338

    Article  PubMed  CAS  Google Scholar 

  • Llovet JM, Fuster J, Bruix J (1999b) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30:1434–1440

    Article  PubMed  CAS  Google Scholar 

  • Llovet JM, Fuster J, Bruix J (2002a) Prognosis of hepatocellular carcinoma. Hepatogastroenterology 49:7–11

    PubMed  Google Scholar 

  • Llovet JM, Real MI, Montana X et al (2002b) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734–1739

    Article  PubMed  Google Scholar 

  • Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907–1917

    Article  PubMed  Google Scholar 

  • Llovet JM, Schwartz M, Mazzaferro V (2005) Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 25:181–200

    Article  PubMed  Google Scholar 

  • Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164–1171

    Article  PubMed  CAS  Google Scholar 

  • Mazzaferro V, Battiston C, Perrone S et al (2004) Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 240:900–909

    Article  PubMed  Google Scholar 

  • Mondazzi L, Bottelli R, Brambilla G et al (1994) Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology 19:1115–1123

    PubMed  CAS  Google Scholar 

  • Poon RT, Ngan H, Lo CM et al (2000) Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol 73:109–114

    Article  PubMed  CAS  Google Scholar 

  • Poon RT, Fan ST, Lo CM et al (2002a) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235:373–382

    Article  PubMed  Google Scholar 

  • Poon RT, Fan ST, Tsang FH et al (2002b) Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective. Ann Surg 235:466–486

    Article  PubMed  Google Scholar 

  • Poon RT, Ng KK, Lam CM et al (2004a) Effectiveness of radiofrequency ablation for hepatocellular carcinomas larger than 3 cm in diameter. Arch Surg 139:281–287

    Article  PubMed  Google Scholar 

  • Poon RT, Ng KK, Lam CM et al (2004b) Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg 239:441–449

    Article  PubMed  Google Scholar 

  • Sala M, Llovet JM, Vilana R et al (2004) Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40:1352–1360

    Article  PubMed  Google Scholar 

  • Savastano S, Miotto D, Casarrubea G et al (1999) Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child’s grade A or B cirrhosis: a multivariate analysis of prognostic factors. J Clin Gastroenterol 28:334–340

    Article  PubMed  CAS  Google Scholar 

  • Shiina S, Teratani T, Obi S et al (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129:122–130

    Article  PubMed  Google Scholar 

  • Shijo H, Okazaki M, Higashihara H et al (1992) Hepatocellular carcinoma: a multivariate analysis of prognostic features in patients treated with hepatic arterial embolization. Am J Gastroenterol 87:1154–1159

    PubMed  CAS  Google Scholar 

  • Takayasu K, Muramatsu Y, Maeda T et al (2001) Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol 176:681–688

    PubMed  CAS  Google Scholar 

  • Tanaka K, Nakamura S, Numata K et al (1998) The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 82:78–85

    Article  PubMed  CAS  Google Scholar 

  • Tateishi H, Oi H, Masuda N et al (1997) Appraisal of combination treatment for hepatocellular carcinoma: longterm follow-up and lipiodol-percutaneous ethanol injection therapy. Semin Oncol 24:S6-81–S86-90

    Google Scholar 

  • Varela M, Sala M, Llovet JM et al (2003) Review article: natural history and prognostic prediction of patients with hepatocellular carcinoma. Aliment Pharmacol Ther 17[Suppl 2]:98–102

    Article  PubMed  Google Scholar 

  • Yamakado K, Nakatsuka A, Akeboshi M et al (2004) Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: short-term recurrences and survival. Oncol Rep 11:105–109

    PubMed  Google Scholar 

  • Yamamoto K, Masuzawa M, Kato M et al (1992) Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization. Cancer Chemother Pharmacol Suppl 31:S77–S81

    Article  Google Scholar 

  • Yamamoto K, Masuzawa M, Kato M et al (1997) Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma. Semin Oncol 24:S6-50–S56-55

    Google Scholar 

  • Yamashita Y, Takahashi M, Koga Y et al (1991) Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer 67:385–391

    Article  PubMed  CAS  Google Scholar 

  • Yoshioka H, Sato M, Sonomura T et al (1997) Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma. Semin Oncol 24:S6-29–S26-37

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic and Interventional Radiology and Nuclear Medicine, Klinikum Bogenhausen, Engelschalkinger Strasse 77, 81925, Munich, Germany

    Thomas K. Helmberger MD (Professor)

Authors
  1. Thomas K. Helmberger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute for Diagnostic and Interventional Radiology University Hospital, Johann Wolfgang Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany

    Thomas J. Vogl MD (Professor) & Martin G. Mack MD (PD) (Professor) &  (PD)

  2. Department of Diagnostic and Interventional Radiology and Nuclear Medicine Klinikum Bogenhausen, Academic Teaching, Hospital of the Technical University Munich, Engelschalkingerstrasse 77, 81925, Munich, Germany

    Thomas K. Helmberger MD (Professor) (Professor)

  3. Department of Clinical Radiology University Hospitals — Grosshadern and Innenstadt, Ludwig-Maximilians-University of Munich, Marchioninistrasse 15, 81377, Munich, Germany

    Maximilian F. Reiser MD (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Helmberger, T.K. (2008). Hepatocellular Carcinoma (HCC). In: Vogl, T.J., Helmberger, T.K., Mack, M.G., Reiser, M.F. (eds) Percutaneous Tumor Ablation in Medical Radiology. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68250-9_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68250-9_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22518-8

  • Online ISBN: 978-3-540-68250-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation